Studies focused on the relationship between CH mutation and cancer showed that an increased risk of haematologic cancers is associated with the existence of CH mutations,10, 13, 14 particularly those harboured by leukaemia driver genes (e.g. DNMT3A, ASXL1, TET2, PPM1D, TP53, RAD21, STAG2, ATM, NF1, CALR, JAK2, CBL, SETD2 and MPL). This evidence concerns the gene TP53 and cancer.